Delivery Order SPE2DB20D3101-SPE2DB25FRVA9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, with a ceiling value of $2,107.58. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $4,456.25 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 420mL of Sucralfate 1 gram/10mL suspension. This order was placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through November 2026. The IDC enables AmerisourceBergen to efficiently deliver a comprehensive range of pharmaceutical products and...
- This is a delivery order under Contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,562,782,604 units of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price ceiling of $3,274.80. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,227.03, is for the supply of 4,565,891,255 units of Sucralfate 1 GM/10 ML Suspension in 420ML containers. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM/10 ML Suspension, a medical product used for treating certain digestive system conditions. The contract has a ceiling value of $2,060.50 and a completion date of October 27, 2023. The contract is a firm fixed-price delivery order, with no...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,583.25 contract is for the delivery of 90 1 GM tablets of the medication Sucralfate. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,339.50, is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract has an ultimate completion date of October 30, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
- The Defense Logistics Agency awarded a $2,290.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sucralfate oral suspension. The contract calls for the delivery of 420 milliliters of sucralfate 1 gram per 10 milliliters oral suspension to a facility in Conshohocken, Pennsylvania. Performance is required between September 28 and 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,730.56, is for the supply of Sucralfate 1 gm/10 ml suspension in 420 ml bottles. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $3,853.95 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561452200 sucralfate 1 gm/10 ml susp ud 10ml. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for delivery of the specified pharmaceutical product between July 10-11, 2023. DLA utilizes indefinite delivery vehicle contracts to supply medical materiel to various DoD components, and this order was placed under one such...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRVA9Delivery Order
The Defense Logistics Agency awarded a $2,366.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for the procurement of Sucralfate 1 GM/10 ML Suspension in a 420 ML quantity. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with the agency. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The current delivery order for Sucralfate, a gastrointestinal protective medication, exemplifies the company's ongoing role as a critical vendor for federal medical procurement needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 9/11/25 |